Despite the importance of immune checkpoint inhibitors (ICPI) in the treatment of melanoma, current methods for PDL1 immunohistochemistry (IHC) do not allow interpretation when the tumor contains abundant melanin that obscures the IHC stain. Here, CD274 is linked to melanoma.